The therapeutic relationship and adherence to antipsychotic medication in schizophrenia

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  McCabe, Rosemarie ^a   Bullenkamp, Jens ^b   Hansson, Lars ^c   Lauber, Christoph ^d   Martinez Leal, Rafael ^e   Rössler, Wulf ^f   Salize, Hans Joachim ^b   Svensson, Bengt ^c   Torres Gonzalez, Francisco ^g   van den Brink, Rob ^h   Wiersma, Durk ^h   Priebe, Stefan ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Fundacion Villablanca   (Spain)

^f UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^g UNIVERSITY OF GRANADA   (Spain)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PREDICTION; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE; DEMOGRAPHY; PHYSICIAN; PROFESSIONAL COMPETENCE; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; TIME; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PROFESSIONAL COMPETENCE; REGRESSION ANALYSIS; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860442673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036080     Document Type: Article

References (34)

1. Velligan DI, Lam F, Ereshefsky L, Miller AL, (2003) Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 54: 665-667.
2. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV, (2002) Prevalence of and risk factors for medication non adherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiat 63: 892-909.
3. Freud S, (1913) The Standard Edition of the Complete Psychological Works of Sigmund Freud London Hogarth Press.
4. Wolfe BE, Goldfried MR, (1988) Research on psychotherapy integration: recommendations and conclusions from a NIMH workshop. J Consult Clin Psych 56: 448-451.
5. Martin DJ, Garske JP, Davic MK, (2000) Relation of the therapeutic alliance to outcome and other variables: a meta-analytic review. J Consult Clin Psych 68: 438-450.
6. Catty J, Winfield H, Clement S, (2007) The therapeutic relationship in secondary mental health care: a conceptual review of measures. Acta Psychiat Scand 116: 238-252.
7. Gehrs M, Goering P, (1994) The relationship between the working alliance and rehabilitation outcomes of schizophrenia. Psychosoc Rehabil J 18: 43-54.
8. Klinkenberg WD, Calsyn RJ, Morse GA, (1998) The helping alliance in case management for homeless persons with severe mental illness. Community Ment Hlt J 34: 569-578.
9. Krupnick JL, Sotsky SM, Simmens S, Moyer J, Elkin I, et al. (1996) The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National programme. J Consult Clin Psych 64: 532-539.
10. Clarkin JF, Hurt SW, Crilly JL, (1987) Therapeutic alliance and hospital treatment outcome. Hosp Community Psych 38: 871-875.
11. Solomon P, Draine J, Delaney MA, (1995) The working alliance and consumer case management. J Ment Health Admin 22: 126-134.
12. Calsyn RJ, Morse GA, Klinkenberg WD, Lemming MR, (2004) Client outcomes and the working alliance in assertive community treatment programs. Care Manag J 5: 199-202.
13. Frank AF, Gunderson JG, (1990) The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiat 47: 228-236.
14. Barnicot K, Katsakou C, Marougka S, Priebe S, (2010) Treatment completion in psychotherapy for borderline personality disorder - a systematic review and meta-analysis. Acta Psychiat Scand pp. 1-12.
15. Brenner MH, Curbow B, Legro MW, (1995) The proximal-distal continuum of multiple health outcome measures: The case of cataract surgery. Med Care 33: AS236-44.
16. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, et al. (2005) Attitudes toward antipsychotic medication: The impact of clinical variables and relationships with health professionals. Arch Gen Psychiat 62: 717-724.
17. Weiss M, Gaston L, Propst A, Wisebord S, Zicherman V, (1997) The role of the alliance in the pharmalogic treatment of depression. J Clin Psychiat 58: 196-204.
18. Gaudiano BA, Miller IW, (2006) Patients' expectancies, the alliance in pharmacotherapy, and treatment outcomes in bipolar disorder. J Consult Clin Psych 74: 671-6.
19. Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC, (2002) Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. J Nerv Ment Dis 190: 597-603.
20. Svensson B, Hansson L, (1999) Relationships among patient and therapist ratings of therapeutic alliance and patient assessments of therapeutic process: A study of cognitive therapy with long-term mentally ill patients. J Nerv Ment Dis 187: 580-586.
21. Priebe S, McCabe R, Bullenkamp J, Hansson R, Lauber C, et al. (2007) Structured patient-clinician communication and one-year outcome in community mental health care: A cluster randomised controlled trial. Brit J Psychiat 191: 420-426.
22. McGuffin P, Farmer A, Harvey I, (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiat 48: 764-770.
23. Priebe S, Gruyters T, (1993) The role of the helping alliance in psychiatric community care: A prospective study. J Nerv Ment Dis 181: 552-557.
24. Junghan UM, Leese M, Priebe S, Slade M, (2007) Staff and patient perspectives on unmet need and therapeutic alliance in community mental health services. Brit J Psychiat 191: 543-547.
25. Buchanan A, (1992) A two-year prospective study of treatment compliance in clients with schizophrenia. Psychol Med 22: 787-97.
26. Kay S, Fiszbein A, Opler L, (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 13: 261-276.
27. Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, et al. (2001) Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis. Eur Psychiat 16: 293-298.
28. Van Os J, Triffaux JM, (2008) Evidence that the Two-Way Communication Checklist identifies patient-doctor needs discordance resulting in better 6-month outcome. Acta Psychiat Scand 118: 322-326.
29. Velligan DI, Lam YWF, Glahn DC, Barrett JA, Maples NJ, et al. (2006) Defining and Assessing Adherence to Oral Anti-Psychotics: A Review of the Literature. Schizophrenia Bull 32: 724-42.
30. Horvath AO, Symonds BD, (1991) Relation between working alliance and outcome in psychotherapy: A meta-analysis. J Couns Psychol 38: 139-149.
31. Neale MS, Rosenheck RA, (1995) Therapeutic alliance and outcome in a VA intensive case management programme. Psychiatr Serv 46: 719-721.
32. Bentall R, Dunn G, Tarrier N, et al. (2012) The influence of therapeutic alliance on the effects of psychological treatment on symptomatic outcome in early schizophrenia patients. J Consult Clin Psych In press.
33. Van Os J, Altamura AC, Bobes J, Gerlach J, Hellewell JSE, et al. (2004) Evaluation of the two-way communication checklist as a clinical intervention. Brit J Psychiat 184: 79-83.
34. McCabe R, Priebe S, (2003) Are therapeutic relationships in psychiatry explained by patients' symptoms? Factors influencing patient ratings. Eur Psychiat 18: 220-225.